2Russi CR,Mocellin S,Pilati P,et al. Phannacokinetics of intrapefitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am, 2003,12 (3) : 781 - 794. 被引量：1
3Glehen O,Stuart OA, Mohamed F, et al. Hyperthermia modifies pharmaeokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Cancer Chemother Phannacol,2004,54( 1 ) :79 - 84. 被引量：1
4Van der Vange N,Van Goethem AR,Zoetmulder FA,et al. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthennic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. Eur J Surg Oncol,2000,26(7):663-668. 被引量：1
5Kobayashi K, Fujimoto S, Takahashi M, et al. A patient with stage Ⅲ c ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intrapefitoneal hyperthermic chemoperfusion. Gan To Kagaku Ryoho, 2003,30( 11 ) : 1726 - 1728. 被引量：1
6Chatzigeorgion K, Economou S,Chrysafis G, et al. Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion ( CIIPHCP). Zentralbl Gynakol,2003,125(10) :424 - 429. 被引量：1
7Ryu KS, Kim JH, Ko HS, et al. Effects of intrapefitoneal hyperthennic chemotherapy in ovarian cancer. Gynecol Oncol, 2004,94(2):325 - 332. 被引量：1
8Hager ED, Dziambor H, Hohmann D, et al. Intraperitoneal hyperthennic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer. Int J Gynecol Cancer,2001,11:57 - 63. 被引量：1
9Chatzigeorgion K, Economou S, Zafiriou G, et al. Continuous Intraoperative Intrapefitoneal Hyperthennic Chemoperfusion (CIIPHCP) in the treatment of advanced stage and recurrent granulosa cell tumors. Report of two cases. Zentralbl Gynakol,2002,124(7) :374 - 377. 被引量：1
10Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intrapefitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer:a phase Ⅱ clinical study.Tumori,2001,87(3) :120 - 126. 被引量：1
